๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A20. Inductible nitric oxide synthase gene therapy for cancer

โœ Scribed by D. Hirst; T. Robson; E. Flitney; J. Worthington; H. McCarthy; J. Coulter; J. Xiang; E. Wagner; N. Page

Book ID
116790381
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
46 KB
Volume
17
Category
Article
ISSN
1089-8603

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Nitric oxide synthase gene therapy enhan
Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells
โœ Catherine Adams; Helen O. McCarthy; Jonathan A. Coulter; Jenny Worthington; Clai ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 206 KB

## Abstract ## Background Nitric oxide (NOยท) derived from donor drugs has been shown to be an effective chemosensitizer __in vitro__. We investigated the combination of inducible nitric oxide synthase (iNOS) gene transfer, driven by a strong constitutive promoter (cytomegalovirus; CMV) with the DN

Human osteocalcin: a strong promoter for
Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer
โœ Helen O. McCarthy; Jonathan A. Coulter; Jenny Worthington; Tracy Robson; David G ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 818 KB

## Abstract ## Background Gene therapy has been identified as a promising treatment strategy for hormone refractory prostate cancer (HRPC). We report, for the first time, the use of the human osteocalcin (hOC) promoter to control inducible nitric oxide synthase (iNOS) transgene expression in HRPC.

Targeting nitric oxide for cancer therap
Targeting nitric oxide for cancer therapy
โœ David Hirst; Tracy Robson ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Pharmaceutical Press ๐ŸŒ English โš– 552 KB
Gene therapy of rat medullary thyroid ca
Gene therapy of rat medullary thyroid cancer by naked nitric oxide synthase II DNA injection
โœ M. N. Soler; P. Bobรฉ; K. Benihoud; G. Lemaire; B. A. Roos; S. Lausson ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 202 KB

## Background: Nitric oxide (no), produced by no synthase ii (nos ii), is the main mediator of the tumoricidal action of activated macrophages. in the present study we examined the potential of the nos ii gene as a suicide gene for medullary thyroid cancer (mtc) therapy. ## Methods: We orthotopic